BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15805003)

  • 1. Acral erythema caused by high-dose methotrexate therapy in patients with osteogenic sarcoma.
    Postovsky S; Ben Arush MW
    Pediatr Hematol Oncol; 2005 Mar; 22(2):167-73. PubMed ID: 15805003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced acral erythema in a pediatric patient with acute monoblastic leukemia.
    Demircioğlu F; Oren H; Yilmaz S; Arslansoyu S; Eren S; Irken G
    Pediatr Hematol Oncol; 2008; 25(3):211-5. PubMed ID: 18432504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-induced bullous acral erythema in a child.
    Werchniak AE; Chaffee S; Dinulos JG
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S93-5. PubMed ID: 15858519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful desensitization to high-dose methotrexate after systemic anaphylaxis.
    Davis KA; Williams P; Walker JC
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):87-9. PubMed ID: 12546343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Burgdorf's reaction (painful acral erythema) in patients with acute lymphoblastic leukemia following medium-dose methotrexate therapy].
    Wysocki M; Nowaczyk-Michalak A; Pilecki O; Kurylak A; Balcar-Boroń A; Trybuś L
    Wiad Lek; 1992 Jun; 45(11-12):462-4. PubMed ID: 1441532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in dose intensity of high-dose methotrexate for nonmetastatic osteosarcoma.
    Leavey PJ; Mantadakis E; Maale G
    Pediatr Hematol Oncol; 2002; 19(7):483-9. PubMed ID: 12217194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High-dose methotrexate with citrovorum factor rescue (HD-MTX-CFR) in the treatment of malignant solid tumors--clinical analysis of 62 patients].
    Wang QL; Sun Y; Zhou JC; Song SZ; Feng FY; Lu L; Yie ZS
    Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):152-4. PubMed ID: 3264785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin in the treatment of severe methotrexate-induced acral erythema.
    Tezer H; Kuskonmaz B; Kara A; Devrim I; Tuncer M; Cengiz AB; Yetgin S; Seçmeer G
    J Pediatr Hematol Oncol; 2008 May; 30(5):391-3. PubMed ID: 18458576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Compatibility and toxicity of methotrexate in the treatment of bone tumors].
    Pongracz N; Kelaridis T; Ritschl P
    Arzneimittelforschung; 1987 Apr; 37(4):456-60. PubMed ID: 3496891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of severe side effects of high-dose methotrexate in osteosarcoma].
    Umeda T; Takada N; Hodaka E; Endoh F; Ishii T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):285-94. PubMed ID: 6582805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy for osteosarcoma--trends in recent years].
    Fujinami S; Nakaseko K; Ogihara Y
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):1908-14. PubMed ID: 8215462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary evaluation of individualized use of large doses of methotrexate for treatment of osteosarcoma in children and adolescents].
    Perek D; Jurczyk-Procyk S; Prokopczyk J; Piekarczyk A; Zelazowski J; Dembowska-Bagińska B; Wieckowska J; Witkowska-Ozogowska J; Kozera M
    Pediatr Pol; 1995 Nov; 70(11):929-37. PubMed ID: 8677159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acral erythema with oral methotrexate in a child.
    Varela CR; McNamara J; Antaya RJ
    Pediatr Dermatol; 2007; 24(5):541-6. PubMed ID: 17958806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases].
    Hueso L; Sanmartín O; Nagore E; Botella-Estrada R; Requena C; Llombart B; Serra-Guillén C; Alfaro-Rubio A; Guillén C
    Actas Dermosifiliogr; 2008 May; 99(4):281-90. PubMed ID: 18394404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of subacute transient cerebral dysfunction in a osteosarcoma patient following high-dose methotrexate].
    Yamada K; Takahashi M; Yoshida M
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):469-72. PubMed ID: 11915742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acral erythema in children receiving high-dose methotrexate.
    Millot F; Auriol F; Brecheteau P; Guilhot F
    Pediatr Dermatol; 1999; 16(5):398-400. PubMed ID: 10571844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate-induced acral erythema with bullous reaction.
    Feizy V; Namazi MR; Barikbin B; Ehsani A
    Dermatol Online J; 2003 Feb; 9(1):14. PubMed ID: 12639472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma.
    Bacci G; Loro L; Longhi A; Bertoni F; Bacchini P; Versari M; Picci P; Serra M
    Anticancer Drugs; 2006 Apr; 17(4):411-5. PubMed ID: 16549998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report].
    Kobayashi H; Morita T; Hirata Y; Kato T; Okada Y; Sato T
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):475-8. PubMed ID: 10740644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.